Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Condition(s):Lung CancerLast Updated:July 20, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Lung CancerLast Updated:July 20, 2016Completed
Condition(s):Pancreatic NeoplasmsLast Updated:September 19, 2016Completed
Condition(s):Lung CancerLast Updated:July 14, 2016Completed
Condition(s):Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral CancerLast Updated:June 18, 2023Completed
Condition(s):Coronary Artery DiseaseLast Updated:August 26, 2019Completed
Condition(s):Colorectal Cancer; Diarrhea; NeutropeniaLast Updated:October 9, 2015Completed
Condition(s):Brain and Central Nervous System Tumors; Neuroblastoma; Sarcoma; Unspecified Childhood Solid Tumor, Protocol SpecificLast Updated:December 23, 2016Terminated
Condition(s):Carcinoma, Transitional CellLast Updated:August 29, 2006Completed
Condition(s):Colorectal CancerLast Updated:July 24, 2008Unknown status
Condition(s):Metastatic Colorectal CancerLast Updated:December 28, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.